Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regression

Dendritic cell (DC) based anti-cancer immunotherapy is well tolerated in patients with advanced cancers. However, the clinical responses seen after adoptive DC therapy have been suboptimal. Several factors including scarce DC numbers in tumors and immunosuppressive tumor microenvironments contribute...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncotarget
Main Authors: Verma, Vivek, Kim, Young, Lee, Min-Cheol, Lee, Jae-Tae, Cho, Sunghoon, Park, In-Kyu, Min, Jung Joon, Lee, Je Jung, Lee, Shee Eun, Rhee, Joon Haeng
פורמט: Artigo
שפה:Inglês
יצא לאור: Impact Journals LLC 2016
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129979/
https://ncbi.nlm.nih.gov/pubmed/27223090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9529
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים